I think we all can agree that the business model that may work well for a large, complex, global company is not effective for a startup. Read More

I think we all can agree that the business model that may work well for a large, complex, global company is not effective for a startup. Read More
The biotech “cluster” of East Cambridge has long been credited with supporting an industry collaboration and knowledge sharing environment not seen on this scale anywhere else, but where is the money Read More
The rules and requirements to remain competitive in today’s marketplace are evolving so rapidly that leadership is struggling to stay ahead of the course. Read More
The TGA performs much the same role as the FDA in the US. Learn about rules supplying 'unapproved' therapeutic goods in clinical trials, Clinical Trial Notification (CTN) and Exemptions. Read More
In the present study, a 100-compound screen was performed (using DILI and control compounds selected based on recent publications7,8) to examine the response of 2D monolayer vs. Read More
Download our latest research paper "Leading Courageously In an Evolving Healthcare Environment". Read More
High turnover in a key scientist role was plaguing this Fortune 500 multinational pharmaceutical company, greatly hindering productivity and advancements in this critical function. Read More
The year that started with the promise of a first-line lung cancer shakeout looks likely to end with Merck & Co’s Keytruda, the drug that started in pole position, even more entrenched than before. Read More
Reliable, long-term supply of key manufacturing components is essential over the lifetime of a biologic. A security of supply program can help maintain manufacturing of vital biopharmaceuticals. Read More
Single-use technologies offer productivity & flexibility benefits to biopharma manufacturers. This WP Life Cycle Assessment (LCA) considers the value chain & multiple environmental impact categories. Read More